A randomized, double-blind, Phase II/III study of JR-013 in the patients with renal anemia receiving hemodialysis treatment
Phase 2
- Conditions
- Renal anemia
- Registration Number
- JPRN-jRCT2080220475
- Lead Sponsor
- KISSEI PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
20 Years and above, Renal anemia patients receiving hemodialysis treatment
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method